Skip to main content

FDA & Health Canada suspend marketing of Trasylol in United State and Canada‏

2007-11-11

November, 5 , 2007, US FDA and Health Canada the American's and Canadian equivalent to the Saudi Food and Drug Authority (SFDA) , announced that at the request of Health Canada and US FDA , the manufacturer Bayer Inc. has temporarily suspended marketing of the drug Trasylol (Aprotinin) pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.

Trasylol (Aprotinin) is drug used to control bleeding during heart surgery and reduce the need for blood transfusion.

Other News

(SFDA) participated in the international conference on pharmaceutical legislation accordant at Japan

2007-11-12

Dr. Saleh Abdullah Bawazeer the Vice President for Drug Affairs and the representative of the Gulf Corporation Council (GCC) in international corporation group which emerge from international conference for accordant, has participated in the conference meeting that held in the city of Yokohama at Japan from 16-20 of shawwal.

Other News

SFDA Launch the Week Of Drug Poisoning Prevention

2007-11-19

Prof. Mohamed Ahmed Al-Kanhal,  Acting Executive President of the (SFDA), stated that the Saudi Food and Drug Authority prepared a long term strategy which aims to present an educational programs concerning about the health, food, drug and how to use the medical devices.

Other News

The Authority holds (The Stability Of Biological Products) Lecture

2007-11-20

In accordance with the continuity of scientific lectures which organized by drug sector and the firms that related to its work, The sector holds a scientific lecture by the name of (the stability of biological products). This has been done within the scientific activity of the drug sector that aims to good preparation and readying to transport some duties.

At the beginning of the ceremony, the vice president for drug affairs Prof. Saleh Abdullah Bawazeer welcomed the honorable attendance and thanks the lecturer Prof. Heuberts Schelekns.

Other News

Inaugurating the Activities of Prevention Week against Drug Poisoning

2007-11-28

His Excellency prof. Mohammed bin Ahmed Alkanhal, the Acting Executive President of the SFDA, inaugurated the activities of prevention week against poisoning during the 14th to the 20th of Thulqida, 1428H, which equals the 24th to the 30th of November, 2007, in Madareem Crown ( Alfahad Crown formerly). The celebration was introduced by Dr. Abdulmuhsin bin Humaid Alruhaimi, the Director of Researches and Publishing Department, and started  a recitation of Holy Quran verses. Then, prof. Alkanhal announced the emblem of the week .. '' Inattentiveness….

Other News

قطاع الدواء يقيم عدد من الفعاليات التثقيفية بمناسبة أسبوع الوقاية من التسمم الدوائي

2007-12-01

شارك عدد من موظفي قطاع الدواء في فعاليات أسبوع الوقاية من التسمم الدوائي وذلك بهدف توعية المجتمع ضد أخطار التسمم الدوائي وما ينجم عن ذلك من تبعات سيئة لاتحمد عقباها، وقد استعانوا بالإحصاءات والبراهين التي تبين حجم هذه المشكلة على أفراد المجتمع السعودي، وبخاصة صغار السن ممن هم دون السادسة. وذلك بإشراف مباشر من مدير إدارة الأبحاث والنشر الدكتور عبدالمحسن الرحيمي.

Other News

MHRA Advises Statin Users

2008-01-12

On January 8, 2008, the Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom's equivalent to the Saudi Food and Drug Authority (SFDA), issued an advise for Statin users in the latest issue of Drug Safety Update newsletter.

Other News

U.S. FDA issues an early communication about ongoing data review of three Cholesterol lowering agents

2008-02-02

On January 26, 2008, the U.S. Food and Drug Administration (FDA), the American equivalent to the Saudi Food and Drug Authority (SFDA), has issued an early communication about ongoing data review for the following cholesterol-lowering agents:

Generic Name

U.S. Trade Name

Saudi Arabia Trade Name(s)

Other News

The Drug Sector Hosts Dr. Thomas Lailouf

2008-02-10

The Drug Sector at The Saudi Food and Drug Authority (SFDA) along with the corporation program of the International Bank hosted Dr. Thomas Lailouf, the expert of drug laboratories and former director of laboratories at the American Food and Drug Administration (FDA), from the 2nd of February 2008 up to the 7th of February 2008 for the purpose of estimating the current status of laboratories concerning the analysis of pharmaceutical products, establishing the visions and appropriate proposition to develop the pharmaceutical products.

Other News

A Legation From German Extedo Company Visits the (SFDA)

2008-02-26


    From 23th , 24th of February, the Drug Sector holds a training program on the assessment of pharmaceutical products file system(EURS is yours) which has been granted by the sector recently. This system used to estimate the electronic registration files. The vice president for drug affairs, the preparation committee, the manager and the employee of registration department has attended the workshop.

Other News

Subscribe to Drugs